Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
DZ1XV8
|
|||
| Drug Name |
LX1004
|
|||
| Drug Type |
Gene therapy
|
|||
| Indication | CLN2 Batten disease [ICD-11: 5C56] | Phase 1/2 | [1] | |
| Company |
Lexeo Therapeutics
|
|||
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | Tripeptidyl-peptidase I (TPP1) | Target Info | . | [1] |
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Clinical pipeline report, company report or official report of Lexeo Therapeutics | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.